Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Lometrexol

Lometrexol

Catalog No.GC18404

El lometexol (DDATHF), un antifolato antipurÍnico, puede inhibir la actividad de la glicinamida ribonucleÓtido formiltransferasa (GARFT), pero no induce niveles detectables de roturas de cadenas de ADN. El lometexol puede inhibir aÚn mÁs la sÍntesis de purina de novo, causando proliferaciÓn celular anormal y apoptosis, incluso la detenciÓn del ciclo celular. El lometexol tiene actividad anticancerÍgena. Lometrexol también es un potente inhibidor de la serina hidroximetiltransferasa1/2 humana (hSHMT1/2).

Products are for research use only. Not for human use. We do not sell to patients.

Lometrexol Chemical Structure

Cas No.: 106400-81-1

Tamaño Precio Disponibilidad Cantidad
1mg
93,00 $
Disponible
5mg
233,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
Glycinamide ribonucleotide formyltransferase (GART) is a folate-dependent enzyme required for de novo purine synthesis. Lometrexol is a folate analog antimetabolite with antineoplastic activity. At nanomolar conentrations, it inhibits GART preventing de novo purine synthesis, inhibiting DNA synthesis, arresting cells in the S phase of the cell cycle, and inhibiting tumor cell proliferation.

Reseñas

Review for Lometrexol

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Lometrexol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.